QULEAP - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
88462494
Word Mark
QULEAP
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
2020-12-14
Filing Date
2019-06-06
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2020-03-17
Attorney Name
Law Office Assigned Location Code
M80
Employee Name
LEASER, ANDREW C
Statements
Goods and Services
Downloadable computer software for drug discovery; downloadable computer software for the purpose of enabling automated molecular design; downloadable computer software for automated molecular design; downloadable computer software for design of molecules and synthetic chemicals using a biomolecular algorithm; downloadable computer software for biomolecule simulation in connection with drug and chemical design; downloadable computer software utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; downloadable computer software for validating novel disease-related targets; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical discovery and development; downloadable computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; downloadable computer software for computational automation of synthetic chemicals; downloadable computer software incorporating machine learning algorithms, models, and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; downloadable computer software for manipulating molecules; downloadable computer software for use in connection with pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, CNS, psychiatry, dermatology, and endocrinology; downloadable computer software for pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases
Goods and Services
Providing temporary use of non-downloadable cloud-based computer software for drug discovery; providing temporary use of non-downloadable cloud-based computer software for the purpose of enabling automated molecular design; providing temporary use of non-downloadable cloud-based computer software for automated molecular design; providing an online, non-downloadable computer software platform for design of molecules and synthetic chemicals using a biomolecular algorithm; providing an online, non-downloadable computer software platform for biomolecule simulation in connection with drug and chemical design; providing an online, non-downloadable computer software platform utilizing artificial intelligence and machine learning for biomolecule simulation and synthetic chemistry; providing an online, non-downloadable computer software platform for validating novel disease-related targets; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate drug and chemical discovery and development; providing temporary use of non-downloadable cloud-based computer software incorporating artificial intelligence and quantum computing functions to automate synthetic chemical discovery and development; providing temporary use of non-downloadable cloud-based computer software for computational automation of synthetic chemicals; providing temporary use of non-downloadable cloud-based computer software incorporating machine learning algorithms, models, and solutions for applications in pharmacology, biopharmaceuticals, energy, and optoelectronics; providing temporary use of non-downloadable cloud-based computer software for manipulating molecules; providing temporary use of non-downloadable cloud-based computer software for use in connection with pharmaceutical research and development in the fields of oncology, immunology, cardiology, pulmonology, CNS, psychiatry, dermatology, and endocrinology; providing temporary use of non-downloadable cloud-based computer software for pharmaceutical research and development in connection with infectious diseases, diabetes, metabolic diseases, internal diseases, and respiratory diseases
Classification Information
International Class
009 - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus. - Scientific, nautical, surveying, electric, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin-operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire-extinguishing apparatus.
US Class Codes
021, 023, 026, 036, 038
Class Status Code
6 - Active
Class Status Date
2019-06-20
Primary Code
009
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-06-20
Primary Code
042
Correspondences
Name
Qulab Inc.
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2019-06-10 | NEW APPLICATION ENTERED IN TRAM |
| 2019-06-20 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-08-28 | ASSIGNED TO EXAMINER |
| 2019-09-03 | NON-FINAL ACTION WRITTEN |
| 2019-09-03 | NON-FINAL ACTION E-MAILED |
| 2019-09-03 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-02-05 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-02-05 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-02-06 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-02-07 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2020-02-11 | ASSIGNED TO LIE |
| 2020-02-26 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2020-03-17 | PUBLISHED FOR OPPOSITION |
| 2020-03-17 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2020-05-12 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2020-09-10 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| 2020-09-10 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| 2020-09-10 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| 2020-09-14 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED |
| 2020-09-14 | WITHDRAWAL OF ATTORNEY GRANTED |
| 2020-12-14 | ABANDONMENT - NO USE STATEMENT FILED |
| 2020-12-14 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
